The Alprazolam Market in 2026 is facing its most significant pharmacological competitive challenge from a new generation of anxiolytic drug candidates that aim to deliver rapid-acting, effective anxiety relief without the physical dependence, abuse liability, sedation, and cognitive impairment that limit the clinical utility and prescribing acceptability of benzodiazepines including...